A Roadmap For Early Development To Commercial Manufacturing

Source: Catalent

A key hurdle for any drug development program is bringing the drug to clinical studies. Astute companies strategize past this milestone and plan for clinical and regulatory success.  Lack of preparation for scale-up activities needed for eventual commercialization can often cause major time delays, increased costs, and a significant amount of rework. In this webcast, industry experts have presented  key topics to consider when planning for scale-up of a development program. Real-life examples to illustrate issues that have resulted in ineffective technology transfers—and strategies that can be employed to overcome these issues. Watch the webinar to learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online